Shared Health Information System for Febrile Neutropenia
关键词
抽象
日期
最后验证: | 03/31/2019 |
首次提交: | 02/19/2017 |
提交的预估入学人数: | 03/14/2017 |
首次发布: | 03/21/2017 |
上次提交的更新: | 04/14/2019 |
最近更新发布: | 04/15/2019 |
实际学习开始日期: | 02/21/2017 |
预计主要完成日期: | 11/29/2019 |
预计完成日期: | 11/29/2019 |
状况或疾病
干预/治疗
Device: NEUTROSIS Intervention Group
相
手臂组
臂 | 干预/治疗 |
---|---|
Experimental: NEUTROSIS Intervention Group The NEUTROSIS Intervention group captures daily its temperature and the occurrence of other symptoms on the smartphone application. This information is then transmitted instantly to the hospital care team through the NEUTROSIS shared information system. The medical oncologist will be alerted in case of fever and will contact the patient. | Device: NEUTROSIS Intervention Group evaluate a shared health information system (NEUTROSIS) for home-hospital management of febrile neutropenia after anti-tumor chemotherapy |
No Intervention: CONTROL Group The control group will monitor daily its temperature and the occurrence of other symptoms on a paper surveillance diary and will have to contact the health team in case of fever as done in the usual care. |
资格标准
有资格学习的年龄 | 18 Years 至 18 Years |
有资格学习的性别 | All |
接受健康志愿者 | 是 |
标准 | Inclusion Criteria: - Age> 18 years - Patient receiving cytotoxic chemotherapy for solid tumor or hematological malignancy - Patient having signed consent to participate in the study - Patient able to understand the protocol of care - Patient covered by health insurance - Patient with the use of a smartphone or tablet with Internet connection Exclusion Criteria: - patient refusing to participate in the study - patient participating in a drug trial - patient receiving or shifting to a weekly chemotherapy protocol |
结果
主要结果指标
1. average length of hospital stay for febrile neutropenia [6 months]
次要成果指标
1. hospitalisation rate [6 months]
2. healthcare use rate [6 months]
3. Use rate [6 months]